ResearcherAichi Medical UniversityNo recent work listed
Norimitsu Yabusaki
Matched on OpenAlex author ID A5024357804. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2016: 2 papers · 2017: 2 papers
Papers 4
- Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. Co-author DOI 10.1016/j.ijsu.2017.01.075↗
- The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. Co-author DOI 10.1016/j.ijsu.2017.01.115↗
- Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Co-author DOI 10.1097/md.0000000000003582↗
- The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the analysis of clinicopathological factors … Co-author DOI 10.1097/md.0000000000004282↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suguru Yamada · 4 shared papers, 2016–2017 · strength 0.24
- Paper The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. DOI 10.1016/j.ijsu.2017.01.115↗
- Paper Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. DOI 10.1016/j.ijsu.2017.01.075↗
- Paper The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the … DOI 10.1097/md.0000000000004282↗
- Hiroyuki Sugimoto · 4 shared papers, 2016–2017 · strength 0.24
- Paper The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. DOI 10.1016/j.ijsu.2017.01.115↗
- Paper Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. DOI 10.1016/j.ijsu.2017.01.075↗
- Paper The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the … DOI 10.1097/md.0000000000004282↗
- Yasuhiro Kodera · 4 shared papers, 2016–2017 · strength 0.24
- Paper The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. DOI 10.1016/j.ijsu.2017.01.115↗
- Paper Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. DOI 10.1016/j.ijsu.2017.01.075↗
- Paper The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the … DOI 10.1097/md.0000000000004282↗
- Tsutomu Fujii · 4 shared papers, 2016–2017 · strength 0.24
- Paper The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. DOI 10.1016/j.ijsu.2017.01.115↗
- Paper Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. DOI 10.1016/j.ijsu.2017.01.075↗
- Paper The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the … DOI 10.1097/md.0000000000004282↗
- Mitsuro Kanda · 3 shared papers, 2016–2017 · strength 0.17
- Paper Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study. DOI 10.1016/j.ijsu.2017.01.075↗
- Paper The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the … DOI 10.1097/md.0000000000004282↗
- Paper Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most … DOI 10.1097/md.0000000000003582↗
- Tomonari Asano · 1 shared paper, 2017 · strength 0.07
- Go Ninomiya · 1 shared paper, 2017 · strength 0.06
- Masamichi Hayashi · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.